CAP
AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation
The consensus guideline offers a two-tier categorization of alleles that are recommended for clinical CYP2D6 pharmacogenetic testing.
Pathology Organizations Update Guideline on Validating Whole-Slide Imaging Digital Pathology Systems
Among their good practice statements, the authors said pathology labs implementing whole-slide imaging for clinical diagnostics should conduct their own validation studies.
In Brief This Week: Danaher, Guardant Health, Invitae, Yourgene Health, and More
News items for the in vitro diagnostics industry for the week of March 29, 2021.
CAP Sends Letter to Congress Supporting $46B Funding for COVID-19 Testing
The organization also supported the recommendation to include $1.75 billion in funding for the US Centers for Disease Control and Prevention.
President Biden Announces Plan to Expand SARS-CoV-2 Testing, Increase Capacity
Under the plan, the president will establish a national pandemic testing board to oversee implementation of a unified approach to testing.